Physician

Alan Bennett Astrow, MD

According to 2025 Medicare claims, Alan Astrow, MD (NPI: 1649384371) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is KINGS PHYSICIAN SERVICES, PC (NPI: 1083045090; TIN: 462333282) and primary practice location at 11215-3609. Astrow is affiliated with the NewYork Quality Care (ACO ID: A2571) and Community Care of Brooklyn IPA, Inc. (ACO ID: A4723), participating under the MSSP model.

Astrow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 134 traditional Medicare patients, billed 493 HCPCS/CPT codes, and received $31,534 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 143 prescription claims across 50 beneficiaries totaling $23,818 in drug costs, led by Exemestane (Exemestane). Open Payments data shows 2 records totaling $45. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $617,946 to $23,818. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	152	368	$26,575
2016	101	227	$21,097
2017	71	198	$19,746
2018	77	188	$17,224
2019	88	217	$19,750
2020	68	176	$15,494
2021	84	181	$17,135
2022	70	152	$14,054
2023	111	191	$19,163
2024	134	493	$31,534

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	72	433	$617,946
2016	56	264	$189,211
2017	15	36	$1,963
2018	13	38	$730
2019	19	59	$11,761
2020	25	103	$9,448
2021	15	34	$1,384
2022	11	54	$1,853
2023	26	75	$19,914
2024	50	143	$23,818

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	33	33	$159
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	37	59	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	91	164	$82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	111	207	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Exemestane	Exemestane	13	930	$986
Anastrozole	Anastrozole	61	3,240	$975
Letrozole	Letrozole	31	1,720	$404
Tamoxifen Citrate	Tamoxifen Citrate	13	1,170	$392

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$45	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan Bennett Astrow, MD?

Tedicare shows public-source Medicare data for Alan Bennett Astrow, MD (NPI 1649384371), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Bennett Astrow, MD have ACO affiliation data?

Alan Bennett Astrow, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571) and Community Care of Brooklyn IPA, Inc. (MSSP, ACO ID A4723).

What billing organization is linked to Alan Bennett Astrow, MD?

Alan Bennett Astrow, MD is linked to KINGS PHYSICIAN SERVICES, PC (billing NPI 1083045090) in the available physician profile data.

Does Alan Bennett Astrow, MD have Open Payments data?

Alan Bennett Astrow, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.